Stay updated on MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial
Sign up to get notified when there's something new on the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page.

Latest updates to the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision history shows addition of v3.3.2 and removal of v3.2.0, reflecting routine record-keeping rather than changes to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange Detected- Removed the site-wide banner about a lapse in government funding and NIH/OPM operating status from the page. The core study history content and controls remain unchanged.SummaryDifference0.8%

- Check41 days agoChange DetectedRecord history shows progressive updates: 2021-12-09 adds Study Status and Contacts/Locations. 2022-01-13 and 2022-04-12 update Recruitment Status and Study Status; 2024-01-25 adds an Oversight entry.SummaryDifference0.1%

- Check63 days agoChange DetectedUpgrade notice and new version v3.2.0 added; previous version v3.1.0 removed.SummaryDifference12%

- Check70 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag.SummaryDifference0.3%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. This appears to be a minor release with a small UI cleanup rather than substantive content changes.SummaryDifference0.7%

Stay in the know with updates to MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 Safety & Efficacy in Melanoma Patients Clinical Trial page.